Welltower's (WELL) healthy Q3 beat and raise reflects robust organic growth trends that drove quarterly funds from operations, UBS said in a Monday research report.
Fundamentals were steady during the quarter as same-store Seniors Housing Operating portfolio net operating income growth continued to be over 20% alongside occupancy gains, according to the note.
Welltower also met investment volume expectations, and the compressed yield reflects the company acquiring properties with significant occupancy upside, analysts wrote.
UBS reiterated its buy rating on the stock and price target of $269 per share.
Price: 228.81, Change: -11.81, Percent Change: -4.91
Comments